- Home
- NMRA vs LAW Comparison
NMRA vs LAW Comparison
Compare NMRA & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- LAW
- Stock Information
- Founded
- NMRA 2019
- LAW 2013
- Country
- NMRA United States
- LAW United States
- Employees
- NMRA N/A
- LAW N/A
- Industry
- NMRA
- LAW Computer Software: Prepackaged Software
- Sector
- NMRA
- LAW Technology
- Exchange
- NMRA Nasdaq
- LAW Nasdaq
- Market Cap
- NMRA 268.5M
- LAW 249.3M
- IPO Year
- NMRA 2023
- LAW 2021
- Fundamental
- Price
- NMRA $1.62
- LAW $5.20
- Analyst Decision
- NMRA Buy
- LAW Buy
- Analyst Count
- NMRA 8
- LAW 2
- Target Price
- NMRA $7.14
- LAW $6.75
- AVG Volume (30 Days)
- NMRA 931.0K
- LAW 156.6K
- Earning Date
- NMRA 08-06-2025
- LAW 08-06-2025
- Dividend Yield
- NMRA N/A
- LAW N/A
- EPS Growth
- NMRA N/A
- LAW N/A
- EPS
- NMRA N/A
- LAW N/A
- Revenue
- NMRA N/A
- LAW $148,024,000.00
- Revenue This Year
- NMRA N/A
- LAW $6.11
- Revenue Next Year
- NMRA N/A
- LAW $6.46
- P/E Ratio
- NMRA N/A
- LAW N/A
- Revenue Growth
- NMRA N/A
- LAW 4.05
- 52 Week Low
- NMRA $0.61
- LAW $3.31
- 52 Week High
- NMRA $17.19
- LAW $6.64
- Technical
- Relative Strength Index (RSI)
- NMRA 51.72
- LAW 80.72
- Support Level
- NMRA $1.56
- LAW $4.80
- Resistance Level
- NMRA $1.78
- LAW $4.98
- Average True Range (ATR)
- NMRA 0.12
- LAW 0.23
- MACD
- NMRA -0.03
- LAW 0.06
- Stochastic Oscillator
- NMRA 58.97
- LAW 97.35
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.